Genotoxicity, Carcinogenicity, and Mutagenesis

Genotoxicity refers to the ability of certain chemicals to damage genetic material, potentially leading to mutations, cancer, or hereditary defects. Carcinogenicity is the potential of a substance to cause cancer, while mutagenesis involves genetic mutations. Advances in molecular biology, genotoxicity assays, and in vitro models help identify and classify these risks, guiding the development of safer pharmaceuticals and chemicals. Regulatory agencies use this data to set exposure limits and approve new drugs.

    Related Conference of Genotoxicity, Carcinogenicity, and Mutagenesis

    November 20-21, 2024

    13th International Conference on Climate Change & Environmental Science

    Rome, Italy
    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Paris, France
    December 18-19, 2024

    3rd International Conference and Expo on Medical Toxicology and Applied Pharmacology

    Zurich, Switzerland
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    March 10-11, 2025

    12th International Conference on Pollution Control & Sustainable Environment

    Rome, Italy
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    April 14-15, 2025

    6th Global Summit on Environmental Health

    Amsterdam, Netherlands
    April 14-15, 2025

    4th World Congress on Climate change and Ecosystem

    Madrid, Spain
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Genotoxicity, Carcinogenicity, and Mutagenesis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in